Allogeneic bone marrow transplantation in aggressive non-Hodgkin's lymphoma (excluding Burkitt and lymphoblastic lymphoma): A series of 73 patients from the SFGM database

British Journal of Haematology

Volumn 107, Issue 1, 1999, Pages 154-161

  Dhedin, N ^a   Giraudier, S ^b   Gaulard, P ^b   Esperou, H ^c   Ifrah, N ^d   Michallet, M ^e   Milpied, N ^f   Rio, B ^g   Cahn, J Y ^h   Molina, L ⁱ   Laporte, J L ^j   Guilhot, F ^k   Kuentz, M ^b  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b HENRI MONDOR HOSPITAL   (France)

^c SAINT LOUIS HOSPITAL   (France)

^d ANGERS UNIVERSITY HOSPITAL   (France)

^e EDOUARD HERRIOT HOSPITAL   (France)

^f HÔTEL DIEU   (France)

^g HÔTEL DIEU   (France)

^h UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

ⁱ HÔPITAL MICHALLON   (France)

^j HÔPITAL SAINT ANTOINE   (France)

^k POITIERS UNIVERSITY HOSPITAL   (France)

more..

Author keywords

Aggressive non Hodgkin's lymphoma; Allogeneic bone marrow transplantation

Indexed keywords

ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CANCER SURVIVAL; FEMALE; FRANCE; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPHENOTYPING; MAJOR CLINICAL STUDY; MALE; MORTALITY; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; SCHOOL CHILD;

ADOLESCENT; ADULT; BONE MARROW TRANSPLANTATION; CAUSE OF DEATH; CHILD; DISEASE PROGRESSION; GRAFT VS HOST DISEASE; HUMANS; IMMUNOPHENOTYPING; LYMPHOMA, NON-HODGKIN; MIDDLE AGED; PROGNOSIS; SURVIVAL ANALYSIS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0032735421     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1999.01666.x     Document Type: Article

References (42)

1. Appelbaum, F.R., Sullivan, K.N., Buckner, C.D., Clift, R.A., Deeg, J., Fefr, A., Hill, R., Martimer, J., Neiman, P.E., Sanders, J.E., Singer, J., Stewart, P., Storb, R. & Thomas, D. (1987) Treatment of malignant lymphoma in 100 patients with chemotherapy total body irradiation and marrow transplantation. Journal of Clinical Oncology, 5, 1340-1347.
2. Bernard, A., Boumsell, L. & Reinherz, L. (1981) Cell surface characterisation of malignant T-cells from lymphoblastic lymphoma using monoclonal antibodies: evidence for phenotypic differences between malignant T-cells from patients with acute lymphoblastic leukemia and lymphoblastic lymphoma. Blood, 57, 1105-1113.
3. Bureo, E., Ortega, J.J., Munoz, A., Cubells, J., Madero, L., Verdaguer, A., Baro, J., Olive, T., Madonado, M.S. & Pardo, N. (1995) Bone marrow transplantation in 46 pediatric patients with non-Hodgkin's lymphoma. Spanish Working Party for Bone Marrow Transplantation in Children. Bone Marrow Transplantation, 15, 353-359.
4. Cabanillas, F., Jannagath, S. & Philip, T. (1990) Management of recurrent or refractory disease. The Non-Hodgkin's Lymphomas (ed. by I. Magrath), pp. 359-371. Edward Arnold, London.
5. Chopra. R., Goldstone, A.H., Pearce, R., Philip, T., Petersen, F., Appelbaum, F., De Val, E. & Ernst, P. (1992) Autologous versus allogeneic bone marrow transplantation for non-Hodgkin's lymphoma: a case controlled analysis of the European bone marrow transplant group registry data. Journal of Clinical Oncology, 10, 1690-1695.
6. Coiffier, B., Gisselbrecht, C. & Herbrecht, R. (1989) LNH-84 regimen: a multicenter study of intensive chemotherapy in 737 patients with aggressive malignant lymphoma. Journal of Clinical Oncology, 7, 1018-1026.
7. Dann, E.J., Daugherty, C.K. & Larson, H. (1997) Allogeneic bone marrow transplantation for relapsed and refractory Hogkin's disease and non-Hodgkin's lymphoma. Bone Marrow Transplantation, 20, 369-374.
8. Dayton, V.B., Arthur, D.C. & Gajl-Peczalska, K.J. (1994) L3 acute lymphoblastic leukemia: comparison with small non-cleaved cell lymphoma inolving the bone marrow. American Journal of Clinical Pathology, 101, 130-139.
9. Fisher, R.I., Gaynor, E.R., Dahlberg, S., et al (1993) Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. New England Journal of Medicine, 328, 1002-1006.
10. Gianni, A.M., Bregni, M., Siena, S., Brambilla, C., Di Nicola, M., Lombardi, F., Gandola, L., Tarella, C., Pileri, A., Ravagnani, F., Valagussa, P. & Bonadonna, G. (1997) High-dose chemotherapy and autologous bone marrow transplantation compared with MACOB-B in aggressive B-cell lymphoma. New England Journal of Medicine, 336, 1290-1297.
11. Gisselbrecht, C., Lepage, E. & Morel, P. (1996) Intensified induction phase including autologous peripheral stem cell transplantation does not improve response rate and survival in lymphoma with at least two adverse prognostic factors when compared to ACVB regimen. International Conference on Malignant Lymphoma, Lugano, 1996, Abstract 470.
12. Gordon, L.I., Harrington, D., Anderson, J., Colgan, J., Glick, J., Neiman, R., Mann, R., Resnick, G.D., Barcos, M., Gottlieb, A. & O'Connel, M. (1992) Comparison of a second-generation combination chemotherapeutic regimen (m-BACOD) with a standard regimen (CHOP) for advanced diffuse non-Hodgkin's lymphoma. New England Journal of Medicine, 327, 1342-1349.
13. Haioun, C., Lepage, E., Gisselbrecht, C., Bastion, J., Coiffier, B., Brice, P., Bosly, A., Dupriez, J., Nouvel, C., Lederlin, P., Biron, P., Brière, J., Gaulard, P. & Reyes, F., for the Groupe d'Etude des Lymphomes de l'Adulte (1997) Benefit of autologous bone marrow transplantation over sequential chemotherapy in poor risk aggressive non Hodgkin's lymphoma: updated results of the prospective study LNH87-2. Journal of Clinical Oncology, 15, 1131-1137.
14. Haioun, C., Lepage, E., Gisselbrecht, C., Coiffier, B., Bosly, A., Tilly, H., Morel, P., Nouvel, C., Herbrecht, R., D'Agay, M.F., Gaulard, P. & Reyes, F. (1994) Comparison of autologous bone marrow transplantation with sequential chemotherapy for intermediate and high grade non-Hodgkin's lymphoma in first complete remission: a study of 464 patients. Journal of Clinical Oncology, 12, 2543-2551.
15. Horning, S.J. (1993) Natural history of and therapy for the indolent non-Hodgkin's lymphoma. Seminars in Oncology, 20, 75-88.
16. Jones, R.J., Ambinder, R.F., Piantadosi, S. & Santos, G.W. (1991) Evidence of a graft versus lymphoma effect associated with allogeneic bone marrow transplantation. Blood, 77, 649-653.
17. Juckett, M., Rowlings, P., Hessner, M., Keever-Taylor, C., Burns, W., Camitta, B., Casper, J., Drobyski, W.R., Hanson, G., Horowitz, M., Lawton, C., Margolis, J., Peitryga, D. & Vesole, D. (1998) T cell-depleted allogeneic bone marrow transplantation for high-risk non-Hodgkin's lymphoma: clinical and molecular follow-up. Bone Marrow Transplantation, 21, 893-899.
18. Kaplan, E.L. & Meier, P. (1958) Nonparametric estimations from incomplete observations. Journal of the American Statistical Association, 53, 457-481.
19. Lundberg, J.H., Hansen, R.M., Chitamber, C.R., Lawton, C.A., Gottlieb, M., Anderson, T. & Ash, R.C. (1991) Allogeneic bone marrow transplantation for relapsed and refractory lymphoma using genotypically IILA-identical and alternative donors. Journal of Clinical Oncology, 9, 1848-1859.
20. Mandigers, C.M., Raemackers, J.M., Schattenberg, A.V., Roovers, E.A., Bogman, M.J., Van der Maazen, R.W., De Pauw, B.E. & De Witte, T. (1998) Allogeneic bone marrow transplantation with T-cell-depleted marrow grafts for patients with poor-risk relapsed low-grade non-Hodgkin's lymphoma. British Journal of Haematology, 100, 198-206.
21. Mendoza, E., Territo, M., Schiller, G., Lill, M., Kunkel, L. & Wolin, M. (1995) Allogeneic bone marrow transplantation for Hodgkin's and non-Hodgkin's lymphoma. Bone Marrow Transplantation, 15, 299-303.
22. Milpied, N., Ifrah, N., Kuentz, M., Maraninchi, D., Colombat, P., Blaise, D. & Harousseau, J.L. (1989) Bone marrow transplantation for adult poor prognosis lymphoblastic lymphoma in first complete remission. British Journal of Haematology, 73, 82-87.
23. Moreau, P., Mechinaud, F., Mahe, B., Le Tortorec, S., Rapp, M.J., Maisonneuve, H., Harousseau, J.L. & Milpied, N. (1996) Successful allogeneic bone marrow transplantation for early relapse after autologous bone marrow transplantation in two casees aggressive high-grade non-Hodgkin's lymphoma. Bone Marrow Tranplantation, 18, 665-667.
24. Nademanee, A.P., Forman, S.J., Schmidt, G.M., Bierman, P.J., Snyder, D.S., O'Donnel, M.R., Lipsett, J.A. & Blume, K.G. (1987) Allogeneic bone marrow transplantation for high risk Non-Hodgkin's lymphoma during first complete remission. Blut, 55, 11-18.
25. Nathwani, B.N., Diamond, L.W., Winberg, C.D., Kim, H., Bearman, R.M., Glick, J.H., Jones, S.E., Gams, R.A., Nissen, N.I. & Rappaport, H. (1981) Lymphoblastic lymphoma: a clinicopathologic study of 95 patients. Cancer, 48, 2347-2355.
26. O'Leary, M., Ramsay, N.K., Nesbit, M.E., Hurd, D., Woods, W.G., Krivit, W., Kim, T.H., McGlave, P. & Kersey, J. (1983) Bone marrow transplantation for non-Hodgkin's lymphoma in children and young adults: a pilot study. American Journal of Medicine, 74, 497-501.
27. Pettengel, R., Radford, J.A., Morgensten, G.R., Scarffe, J.H., Harris, M., Woll, P.J., Deakin, D.P., Ryder, D., Wilkinson, P.M. & Crowther, D. (1996) Survival benefit from high dose therapy with autologous blood progenitor-cell transplantation in poor prognosis non-Hodgkin's lymphoma. Journal of Clinical Oncology, 14, 586-592.
28. Philip, T., Armitage, J.O., Spitzer, G., Chauvin, F., Jagannath, S., Cahn, J.Y., Colombat P., Goldstone, A.H., Gorin, N.C., Flesh, M., Laporte, J.P., Maraninchi, D., Pico, J., Bosly, A., Anderson, C., Schots, R., Biron, P., Cabanillas, F. & Dicke, K. (1987) High dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma. New England Journal of Medicine, 316, 1493-1498.
29. Philip, T., Guglielmi, G., Hagenbeck, A., Somers, R., Van der Lelic, H., Bron, D., Sonneveld, P., Gisselbrecht, C., Cahn, J.Y., Harousseau, J.L., Coiffier, B., Biron, T., Mandelli, F. & Chauvin, F. (1995) Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma. New England Journal of Medicine, 333, 1540-1545.
30. Philips, G.L., Herzig, R.H., Lazarus, H.M., Fay, J.W., Griffith, R. & Herzig, G. (1986) High-dose chemotherapy. Fractionated total-body irradiation, and allogeneic marrow transplantation for malignant lymphoma. Journal of Clinical Oncology, 4, 480-488.
31. Ratanatharathorn, V., Uberti, J., Karanes, C., Abella, E., Lum, L.G., Momin, F., Cummings, G. & Sensenbrenner, L.L. (1994) Prospective comparative trial of autologous versus allogeneic transplantation in patients with non-Hodgkin's lymphoma. Blood, 84, 1050-1055.
32. Schouten, H.C., Armitage, J.O., Klassen, L.W., Vaughan, W.P., Bierman, P.J., Weisenburgen, D. & Kessinger, A. (1989) Allogeneic bone marrow transplantation in patients with lymphoma relapsing after autologous marrow transplantation. Bone Marrow Transplantation, 4, 119-121.
33. Shepherd, J.D., Barnett, M.J., Connors, J.M., Spinelli, J.J., Sutherland, H.J., kingemann, H.G., Nantel, S.H., Reece, D.E., Currie, C.J. & Phillips, G.L. (1993) Allogeneic bone marrow transplantation for poor-prognosis non-Hodgkin's lymphoma. Bone Marrow Transplantation, 12, 591-596.
34. Slavin, S., Nagler, A., Naparstek, E., Kapelushnik, Y., Aker, M., Cividalli, G., Varadi, G., Kirschbaum, H., Ackerstein, A., Samuel, S., Amar, A., Brautbar, C., Ben-Tal, O., Eldor, A. & Or, R. (1998) Nonmycloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases. Blood, 91, 756-763.
35. + T cell-depleted allogeneic bone marrow transplantation for non-Hodgkin's lymphoma. Bone Marrow Transplantation, 21, 1177-1181.
36. The Non-Hodgkin's Lymphoma (NHL) Pathologic Classification Project (1982) National Cancer institute sponsored study of classification of non-Hodgkin lymphomas: a summary and description of the working formulation for clinical usage. Cancer, 49, 2112-2135.
37. Troussard, X., Leblond, V., Kuentz, M., Milpied, N., Jouet, J.P., Cordonier, C., Leporrier, M. & Vernant, J.P. (1990) Allogeneic bone marrow transplantation in adults with Burkitt's lymphoma or acute lymphoblastic leukemia in first complete remission. Journal of Clinical Oncology, 8, 809-812.
38. Van Besien, K., Sobocinski, K.A., Rowlings, P.A., Murphy, S.C., Armitage, J.O., Bishop, M.R., Chaekal, O.K., Gale, R.P., Klein, J.P., Lazarus, H.M., McCarty, P.L., Raemaekers, J.M., Reiffers, J., Philips, G.L., Schattenberg, A.V., Verdonck, L.F., Vose, J.M. & Horowitz, M.M. (1998) Allogeneic bone marrow transplantation for low-grade lymphoma. Blood, 92, 1832-1836.
39. Van Besien, K.M., De Lima, M., Giralt, S.A., Moore, D.F., Khouri, J.F., Rondon, G., Mehra, R., Anderson, B.S., Dyer, C., Cleary, K., Przepiorka, D., Gajewski, J.L. & Champlin, R.E. (1997) Management of lymphoma recurrence after allogeneic transplantation: the relevance of graft-versus-lymphoma effect. Bone Marrow Transplantation, 19, 977-982.
40. Van Besien, K.M., Khouri, I.F., Giralt, S.A., McCarthy, P., Mehra, R., Anderson, B.S., Przepiorka, D., Gajewski, J.L., Bellare, N. & Nath, R. (1995) Allogeneic bone marrow transplantation for refractory and recurrent low-grade lymphoma: the case for aggressive management. Journal of Clinical Oncology, 13, 1096-1102.
41. Van Besien, K.W., Mehra, R.C., Giralt, S.A., Kantarjian, H.M., Pugh, W.C., Khouri, I.F., Moon, Y., Williams, P., Anderson, B., Przepiorka, D., McCarthy, P.L., Gajewski, J.L., Deisseroth, A.B., Cabanillas, F. & Champlin, R. (1996) Allogeneic bone marrow transplantation for poor-prognosis lymphoma: response, toxicity, and survival depend on disease histology. American Journal of Medicine, 100, 299-307.
42. Verdonck, L.F., Dekker, A.W., Lokhorst, H.M., Petersen, E.J. & Nieuwenhuis, H.K. (1997) Allogeneic versus autologous bone marrow transplantation for refractory and recurrent low-grade non-Hodgkin's lymphoma. Blood, 90, 4201-4205.